Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF in adolescents with chronic hepatitis B
ChiCTR2200063808Phase 4Recruiting
- Sponsor
- Zhenjiang Third People's Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tenofovir alafenamide in Chronic Hepatitis B (CHB), sponsored by Zhenjiang Third People's Hospital. Primary endpoints: HBV DNA, ALT and 5 more. Started Jan 2023; status: recruiting.
02
Drugs
tenofovir alafenamide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2200063808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063808.